NCT07836933

Cancer Oriented Understanding and Navigation Via Supportive and Educational Language Models (COUNSEL)

Not Yet Recruiting · Not Applicable · University of California, San Francisco · registry updated 2026-09-28

Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.

A randomized, open-label behavioral study designed to evaluate the feasibility, acceptability, and early impact of a large language model (LLM)-based artificial intelligence (AI) tool to support patient understanding following an initial oncology consultation.

Inclusion

Age ≥18 years.
Histologically or cytologically confirmed diagnosis of localized prostate cancer
Newly diagnosed and planning to undergo or recently completed a radiation or surgical oncology consult at University of California, San Francisco (UCSF)
Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
English-speaking and able to participate in study teleconferences
Ability to understand and willingness to sign a written informed consent document

Exclusion

Prior definitive treatment for prostate cancer (e.g., surgery, radiation, or systemic therapy)
Cognitive, sensory, or language impairment that would interfere with the ability to understand, participate in, or complete the study procedures
Inability or unwillingness to participate in two study-related teleconferences
Current enrollment in another interventional clinical trial that may interfere with study participation
Inability to comply with protocol requirements (e.g., completing surveys or using the information-tracking log)

Open NCT07836933 on ClinicalTrials.gov All conditions